Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 16.35%8.45B | 15.04%2.21B | 15.76%2.16B | 16.68%2.09B | 18.17%1.99B | 16.78%7.26B | 16.74%1.92B | 16.69%1.87B | 16.36%1.79B | 17.38%1.68B |
Operating revenue | 16.35%8.45B | 15.04%2.21B | 15.76%2.16B | 16.68%2.09B | 18.17%1.99B | 16.78%7.26B | 16.74%1.92B | 16.69%1.87B | 16.36%1.79B | 17.38%1.68B |
Cost of revenue | 16.83%2.07B | 17.39%540M | 19.10%530M | 14.06%511M | 17.27%489M | 3.27%1.77B | 1.48%460M | 2.11%445M | 5.89%448M | 3.52%417M |
Gross profit | 16.20%6.38B | 14.30%1.67B | 14.71%1.63B | 17.55%1.57B | 18.47%1.5B | 21.93%5.49B | 22.53%1.46B | 22.15%1.42B | 20.34%1.34B | 22.79%1.27B |
Operating expense | 10.80%5.88B | 9.98%1.52B | 9.90%1.47B | 12.28%1.46B | 11.66%1.44B | 12.32%5.31B | 7.89%1.38B | 12.05%1.33B | 13.62%1.3B | 16.50%1.29B |
Selling and administrative expenses | 14.47%3.25B | 13.37%848M | 14.57%818M | 17.46%814M | 13.68%781M | 15.86%2.84B | 12.32%748M | 14.44%714M | 15.70%693M | 21.99%687M |
-Selling and marketing expense | 13.70%2.43B | 12.72%629M | 15.24%620M | 16.60%611M | 10.40%573M | 15.75%2.14B | 13.92%558M | 14.42%538M | 14.24%524M | 20.89%519M |
-General and administrative expense | 16.81%820M | 15.26%219M | 12.50%198M | 20.12%203M | 23.81%208M | 16.23%702M | 7.85%190M | 14.50%176M | 20.49%169M | 25.50%168M |
Research and development costs | 6.57%2.63B | 5.98%673M | 4.52%647M | 6.39%649M | 9.33%656M | 8.50%2.46B | 3.10%635M | 9.42%619M | 11.35%610M | 10.80%600M |
Operating profit | 172.68%499M | 89.87%150M | 87.50%165M | 208.33%111M | 420.00%64M | 182.43%183M | 189.01%79M | 434.33%88M | 205.64%36M | 72.54%-20M |
Net non-operating interest income expense | 11.76%57M | 39.53%60M | 88.24%64M | 3,840.00%187M | 221.86%59M | 3,036.53%51M | 387.70%43M | 439.63%34M | ||
Non-operating interest income | ---- | ---- | 7.50%86M | 22.22%88M | 47.62%93M | 210.31%301M | 86.99%87M | 155.98%80M | 373.25%72M | 1,472.25%63M |
Non-operating interest expense | ---- | ---- | 0.00%29M | -3.45%28M | 0.00%29M | 11.76%114M | -0.70%28M | -2.11%29M | -3.85%29M | 106.88%29M |
Other net income (expense) | 1,092.86%139M | -30M | 150.00%5M | -200.00%-3M | 28.57%-5M | 57.58%-14M | 0 | -494.17%-10M | 116.81%3M | 31.05%-7M |
Special income (charges) | ---84M | ---75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Less:Restructuring and merger&acquisition | --84M | --75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 1,692.86%223M | --45M | 150.00%5M | -200.00%-3M | 28.57%-5M | 57.58%-14M | --0 | -494.17%-10M | 116.81%3M | 31.05%-7M |
Income before tax | 79.21%638M | -13.04%120M | 75.97%227M | 104.88%168M | 1,657.14%123M | 236.92%356M | 276.99%138M | 682.18%129M | 222.63%82M | 107.53%7M |
Income tax | 110.93%112M | 102.48%26M | 126.67%34M | 1,100.00%36M | 128.57%16M | -1,057.94%-1.03B | -2,288.46%-1.05B | -71.46%15M | 210.74%3M | -23.64%7M |
Net income | -61.91%526M | -92.09%94M | 69.30%193M | 67.09%132M | 107M | 476.29%1.38B | 1,043.25%1.19B | 252.57%114M | 223.13%79M | 0 |
Net income continuous Operations | -61.91%526M | -92.09%94M | 69.30%193M | 67.09%132M | --107M | 476.29%1.38B | 1,043.25%1.19B | 252.57%114M | 223.13%79M | --0 |
Minority interest income | ||||||||||
Net income attributable to the parent company | -61.91%526M | -92.09%94M | 69.30%193M | 67.09%132M | 107M | 476.29%1.38B | 1,043.25%1.19B | 252.57%114M | 223.13%79M | 0 |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -61.91%526M | -92.09%94M | 69.30%193M | 67.09%132M | 107M | 476.29%1.38B | 1,043.25%1.19B | 252.57%114M | 223.13%79M | 0 |
Basic earnings per share | -62.50%1.98 | -92.26%0.35 | 69.77%0.73 | 66.67%0.5 | 0.4 | 466.67%5.28 | 1,022.45%4.52 | 248.28%0.43 | 220.00%0.3 | 0 |
Diluted earnings per share | -62.57%1.95 | -92.08%0.35 | 67.44%0.72 | 63.33%0.49 | 0.4 | 461.81%5.21 | 1,002.04%4.42 | 248.28%0.43 | 220.00%0.3 | 0 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |